Delivery Order SPE2DB24D1205-SPE2DB24FCUGS
Award Date
9/3/24
Potential Completion Date
9/24/24
Potential Value
$13K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of the prescription medication VYNDAMAX 61 MG CAPSULE UD 30S. The $12,960.30 firm fixed-price delivery order contract has an ultimate completion date of August 29, 2024. The award is not associated with any set-aside program. As a key supplier of medical commodities to the U.S. government, Amerisourcebergen holds several Indefinite...
This federal contract award, valued at $12,960.30, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is a delivery order for the pharmaceutical product VYNDAMAX 61 MG CAPSULE UD 30S, with a performance period through September 30, 2024. The contract type is firm fixed price. This award is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, under which AmerisourceBergen...
This federal contract award, with ID SPE2DB24D1021|SPE2DB25FEVCE, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $13,408.24, is for the delivery of VYNDAMAX 61 MG CAPSULE UD 30S, a pharmaceutical product. This is a firm fixed-price delivery order contract with an ultimate completion date of April 10, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract, valued at $25,920.62, is for the delivery of VYNDAMAX 61 MG CAPSULE UD 30S, a prescription medication. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, valued at up to...
This federal contract award, with ID SPE2DB22D2206|SPE2DB24FHS75, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,960.30 firm fixed-price delivery order is for the supply of the prescription drug VYNDAMAX 61 MG CAPSULE UD 30S, with a completion date of July 5, 2024. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This federal contract award SPE2DX15D3007|SPE2DX24F9P2Y was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4565531326 VYNDAMAX 61 MG CAPSULE UD 30S. The $12,960.30 firm fixed price delivery order has an ultimate completion date of September 12, 2024 and does not utilize any set-aside designations. Amerisourcebergen, as the prime contractor, will be supplying this...
This federal contract award, valued at $12,960.30, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of VYNDAMAX 61 MG CAPSULE UD 30S. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of October 3, 2024. There is no set-aside designation for this award. AmerisourceBergen, through its Corporate Office division, has been a significant supplier of pharmaceutical products and medical...
This federal contract award, valued at $12,960.30, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of VYNDAMAX 61 MG CAPSULE UD 30S and has a completion date of November 8, 2024. The contract type is Delivery Order with a Firm Fixed Price pricing structure. This award is not designated as a Set-Aside contract. Amerisourcebergen Drug Corp is a for-profit organization registered in the System...
This federal contract award, valued at $12,960.30, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of VYNDAMAX 61 MG CAPSULE UD 30S, a pharmaceutical product. The contract has an ultimate completion date of October 10, 2024 and is a firm fixed-price Delivery Order. This contract does not have a set-aside designation. AmerisourceBergen, through its Corporate Office division, is the prime...
This federal contract award, with an ID of SPE2DB20D3303|SPE2DB24FZ9X4, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,960.30, is for the delivery of VYNDAMAX 61 MG CAPSULE UD 30S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of July 5, 2024. Amerisourcebergen Drug Corp is the...